Killing of target cells by redirected granzyme B in the absence of perforin
Open Access
- 4 March 2004
- journal article
- Published by Wiley in FEBS Letters
- Vol. 562 (1-3) , 87-92
- https://doi.org/10.1016/s0014-5793(04)00187-5
Abstract
Granzyme B (GzmB) is a potent apoptosis‐inducing serine protease of cytotoxic lymphocytes. Following receptor‐mediated endocytosis, GzmB is supposed to enter the cytosol through perforin‐mediated membrane disruption. We investigated whether retargeting of GzmB to Lewis Y positive surface receptors could lead to perforin‐independent target cell death. We coupled recombinant GzmB to the Lewis Y‐binding antibody dsFv‐B3. Targeting of GzmB to Lewis Y positive cells triggered cell death with similar efficacy as dsFv‐B3 targeted Pseudomonas exotoxin fragment 38 (PE38). Since GzmB was only weakly inhibited by plasma proteins, GzmB‐based immunoconjugates should be useful as a new class of immunotoxins with low immunogenicity utilizing programmed cell death for therapeutic purposes.Keywords
This publication has 23 references indexed in Scilit:
- Crystal structure of the apoptosis-inducing human granzyme A dimerNature Structural & Molecular Biology, 2003
- Delivering the kiss of deathNature Immunology, 2003
- A clathrin/dynamin- and mannose-6-phosphate receptor–independent pathway for granzyme B–induced cell deathThe Journal of cell biology, 2003
- Membrane Traffic Exploited by Protein ToxinsAnnual Review of Cell and Developmental Biology, 2002
- Structural basis for the activation of human procaspase-7Proceedings of the National Academy of Sciences, 2001
- The Immunological Synapse of CTL Contains a Secretory Domain and Membrane BridgesImmunity, 2001
- Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with ApoptosisJournal of Biological Chemistry, 1998
- New Paradigm for Lymphocyte Granule-mediated CytotoxicityJournal of Biological Chemistry, 1996
- Treatment of advanced solid tumors with immunotoxin LMB–1: An antibody linked to Pseudomonas exotoxinNature Medicine, 1996
- A recombinant immunotoxin containing a disulfide-stabilized Fv fragment.Proceedings of the National Academy of Sciences, 1993